Member Info for TorquayFan

Chester yes - it's great news that Vulpes have bought again. Coupled with the buy out of £1 million of CLNs and the evident optimism of CEO and CFO on the cash flow front, it's looking good. Sath said within a year, about the timing of the expected cash inflow, but I'm guessing they firmly expect something much sooner than that. We'll see.

All in all, we're set fair for an exciting few months . . . . .

Thanks Johnny. Crikey they don't want much do they ?

It's hard to know what it's all about but Genmab obviously have serious plans in the UK.

Chester. Perhaps you should have explained that your original post was a 'riposte'. In future, please advise when one of your posts is not to be taken seriously. I reject that my reply was a 'rant'. Sarcastic at the start maybe, but otherwise polite enough. No hard feelings but there it is. The serious answer is much better. ATB

Cleaner. Thanks for your13.09. Great link. Listened again.

(Far better than the other guff!)

EE. Spot on ! Thanks.

Chester - "Simples" ? Really ? Perhaps you should offer your services to the BoD. Sath may have a lot to learn from you.

Sorry but this statement means precisely what - "The intention and means will be a negotiating tool". With respect, isn't that gobbledegook ?

And, "So the illusion of going it alone is what matters when faced with a potential suitor". What the hell ? You think big Pharma will fall for that?

The bundle of science has never been enough to get the SP up, so far at least. And to raise the tens of millions needed at 10-15p will involve horrendous dilution. As for lining up "Institutional Investors, Banks and . . . Shareholders ". MMmmm.

Chester - you can't be serious with these posts, Sir. You are one of my 'watch for' Posters, but this time my comment is, 'stop digging'. My last on this BFN and ATB

Marcus thanks very much for that reply - I'll work at it !

Chester, Thanks for clarifying. How exactly do you think that Scancell can come up with a credible "strategy combined with a financial plan to go it alone" ? 'Going it alone' is surely a practical impossibility.

You get 'A star' when that's explained. No AI please.

Botski - you present that the establishment of Glymab can protect us from a low ball offer. I asked, "How exactly does that work, Glymab being a 100% subsidiary of Scancell?"

Could you please explain it for the BB in your own words, (because as you know it is your own thoughts I am interested in).

Marcus - thanks for that. Sorry to be dim, but regarding DAC's being the 'next' generation as said, is that after the (hopefully) generation of CI's and Modi/iSCIB1+ etc. OR in parallel ? Myself, I don't understand it enough to put context to it.

Anyone?

Cleaner. I know we agree to disagree on the 'helpfulness' of AI in the Scancell context . . . . it would have been great to see that whole sequence of Chilltime's excellent posts, for examination by human intelligence instead. Please conside an AI 'desist'. Can we really be so desperate to post that we have to clutter up the BB so?

Perhaps you could ask LSE to set up a seperate BB to handle AI scripts and discussion?

Chester, arising or not from AI, (no quotation marks applied), this comment, "prudent to show you have a strategy combined with a financial plan to go it alone" seems to me to be, a bit fanciful - the bundle of Scancell's science, in realism, cannot be taken to fruition without deals and partnerships. And that's what I'm expecting, sooner maybe, rather than later. 'Going it alone' is surely a practical impossibility.

Hi Botski. Re. this - the establishment of Glymab, "protecting us from a low ball offer". Sorry to query it, but how exactly does that work, Glymab being a 100% subsiary of Scancell? ATB

Konar - your 12.15 yesterday - thanks very much. You got 27 recs so many have seen it, but just in case, here it is again :-

""I don't know if this particular comment was picked up on yesterday, but in the QA session in response to why the CLN notes were paid down by a million Sath said "given our runway, and our *confidence* in our runway, there was a small partial redemption"

If you had no idea where the next money was coming from, would you give back the money needed to keep the lights on? ""

Re. your conclusion - spot on ! To repay £1 million of the CLNs shows great confidence in the cash flows. Also good to see some exposure here and there today. Scancell is beginning to bubble. ATB

Yes Chelsea you 'told us so'. Well done.

It's OK to discuss different ideas you know.

Thanks Marcus. It seems Pharma are quite happy to splash the money, this time on early stage candidates. Just MHO, I wonder where deals like this might place a partial of or a whole acquisition of Scancell. My mind boggles. Roll on the day!

Thanks Chester. I subscribe to the EE theory a few days ago - there's a good possibility of some 'news' before Thursday. CEO might be aiming to explain further at the presentation. MMmmm.

Crusty - understand your concerns but there are all sorts of reasons why 1.6 million shares might be divested even though the prospects for exciting news soon and for the longer future, are good.

Vascular - I think it extremely unlikely a) that there is any disappointing news coming and b) that there has been any kind of leak, (IF there were some to leak! ). Scancell seems to have been a very tight ship over the years. Regarding the usual concern of a potential raise, in recent updates Scancell have made confident comments about the cash situation. And a one million trade is a tiny portion of the total share capital.

We'll be getting an update in less than a week so IMO we have to see what the next week brings.

GL too

Hey Violin. It's being so cheerful that keeps you going. That said, I sympathise. But the SP is almost irrelevant. Hang on sloopy !

Yes I'll echo that. Thanks Burble.

"NHS England is working to ensure there is an integrated infrastructure to support national roll out of new treatments if they prove effective". And re. EE - “We hope this will also be the case for larger registrational studies in the future”.

Scancell being one of 2 Companies involved in the CVLP, there must be some hope that iSCIB1+ could look forward to the swiftest possible development to product stage.

"On Aug. 8, the NHS noted that CVLP had already helped refer around 550 patients to trials of vaccines for bowel and skin cancer." Hopefully Scancell figure positively in that 550 !

Some nice signals there . . .thanks to Pink Sheet and CEO !

WTP thanks. I got this far . . . . "As the CVLP prepares to support its third cancer vaccine trial, the Pink Sheet examined Scancell’s experience with the initiative, which the drug company used to recruit patients for its advanced melanoma vaccine trial.

Key Takeaways. Scancell has shared positive feedback from its partnership with the NHS England’s Cancer Vaccine launchpad (CVLP), which it used accelerated patient recruitment for its melanoma vaccine trial"

I tried signing up for a free trial but 'twas a 'no go'.

Chester, just a typo. In the headline it's spelt right.